Join our teams!
We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.
employees, including 4,900 in France.
patients treated each day worldwide with Servier Group medicines.
of revenue from brand-name medicines invested in R&D in 2019/2020.
euros in revenue in 2019/2020 comprising €3.3 billion for brand-name medicines and €1.4 billion for generic medicines.
oncology, immune-inflammatory and neurodegenerative diseases, cardiometabolism.
We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.
Colorectal cancer is a common disease. It is one of the most frequently diagnosed cancers in the world: it ranks third, behind lung cancer and liver cancer, and it affects almost as many women as men.
SMART is Servier’s medical image bank dedicated to healthcare professionals. The diversity of the 3,000 free medical images available makes it easy to illustrate all types of presentations or publications.
Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.